CEO of Guardant Health Inc (30-Year Financial, Insider Trades) Helmy Eltoukhy (insider trades) sold 160,886 shares of GH on 01/25/2021 at an average price of $158.94 a share. The total sale was $25.6 million.
Guardant Health Inc has a market cap of $14.99 billion; its shares were traded at around $149.910000 with and P/S ratio of 53.09. GuruFocus has detected 1 severe warning sign with Guardant Health Inc. .
CEO Recent Trades:
- CEO Helmy Eltoukhy sold 160,886 shares of GH stock on 01/25/2021 at the average price of $158.94. The price of the stock has decreased by 5.68% since.
- CEO Helmy Eltoukhy sold 489,114 shares of GH stock on 01/21/2021 at the average price of $162.27. The price of the stock has decreased by 7.62% since.
- CEO Helmy Eltoukhy sold 150,000 shares of GH stock on 01/15/2021 at the average price of $158.39. The price of the stock has decreased by 5.35% since.
Directors and Officers Recent Trades:
- Director Stanley J Meresman sold 4,934 shares of GH stock on 01/11/2021 at the average price of $142. The price of the stock has increased by 5.57% since.
- Director Ian T Clark sold 2,690 shares of GH stock on 01/04/2021 at the average price of $129.23. The price of the stock has increased by 16% since.
- Director Ian T Clark sold 538 shares of GH stock on 12/28/2020 at the average price of $135. The price of the stock has increased by 11.04% since.
For the complete insider trading history of GH, click here
.This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
